Arusha Ayub | Medicine and Dentistry | Best Scholar Award

Best Scholar Award

Arusha Ayub
King Saud University, Riyadh, Saudi Arabia

Arusha Ayub
Affiliation King Saud University, Riyadh
Country Saudi Arabia
Google Scholar Profile vFU3lOYAAAAJ
Documents 54
Citations 191
h-index 5
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards
ORCID 0009-0009-5972-1842

Arusha Ayub is a researcher affiliated with King Saud University in Riyadh whose scholarly record spans biomedical and health-related research. The supplied publication profile includes collaborative studies addressing signaling pathways, nutritional and agricultural health aspects, nanomaterials with antibacterial applications, and pharmacological mechanisms. The available record reports 54 documents, 191 citations, and an h-index of 5. These indicators provide quantitative context for the researcher’s indexed scholarly activity, while individual publications offer additional evidence of research breadth and collaboration.

Abstract

Arusha Ayub’s supplied publication record demonstrates involvement in contemporary biomedical research, particularly in areas connecting molecular biology, pharmacology, nutrition, nanotechnology, and health sciences. Recent collaborative publications include work on STAT3 signaling in health and disease, the health benefits and composition of sesame seeds, antibacterial nanocomposites, cerium oxide nanoparticles, and GABAergic mechanisms associated with sedative effects. [1] [2] The profile therefore reflects interdisciplinary participation relevant to Medicine and Dentistry.

Keywords

Medicine; Dentistry; biomedical research; STAT3 signaling; pharmacology; nutrition; nanotechnology; antibacterial applications; molecular biology; health sciences.

Introduction

Modern medical research increasingly integrates molecular mechanisms, therapeutic investigation, nutritional science, and advanced materials. Ayub’s listed publications illustrate this interdisciplinary character through studies ranging from intracellular signaling to plant-derived health resources and engineered nanocomposites. Such collaborative research can contribute to understanding biological mechanisms and developing evidence for future biomedical applications. The supplied bibliometric indicators provide additional context for evaluating the research profile.

Research Profile

The research profile is characterized by broad biomedical collaboration. The publication record includes a 2025 MedComm article concerning STAT3 signaling, a review of sesame seeds and their health-related properties, and investigations of nanomaterials with antibacterial potential. [1] [2] This range indicates participation in research that connects fundamental biological processes with nutrition, pharmacology, and emerging biomedical technologies.

Research Contributions

  • Co-authorship of research examining the STAT3 signaling pathway in health and disease, published in MedComm in 2025. [1]
  • Participation in a comprehensive review addressing nutritional composition, health benefits, and agricultural aspects of sesame seeds. [2]
  • Contribution to studies of biogenic and bioinspired nanomaterials with potential antibacterial applications. [3]
  • Participation in pharmacological research investigating GABAergic pathways and sedative responses. [5]

Publications

  1. STAT3 Signaling Pathway in Health and Disease. MedComm, 2025, 6(4), e70152.[1]
  2. A Comprehensive Review of the Health Benefits, Nutritional Composition, and Agricultural Aspects of Sesame Seeds. Journal of Food Biochemistry, 2025. [2]
  3. Bioinspired sustainable development of Ag-CuO/MWCNT nanocomposites for antibacterial applications. Microbial Pathogenesis, 2025, 203, 107516. [3]
  4. Green and Biogenic Synthesis of Cerium Oxide (CeO2) Nanoparticles. ChemistrySelect, 2025, 10(18), e202406123. [4]
  5. Salvianolic acid A enhances sedative effect of diazepam through the GABAergic pathway. Neurotoxicology and Teratology, 2025. [5]

Research Impact

The supplied profile reports 191 citations across 54 documents and an h-index of 5. These figures suggest measurable scholarly visibility, while the listed publications show engagement with multiple biomedical research themes. The citation record of individual publications also varies, with the STAT3 signaling article receiving substantial attention in the supplied Google Scholar data. [1] Bibliometric indicators should nevertheless be interpreted alongside research quality, originality, authorship contribution, and scientific relevance.

Award Suitability

The available evidence provides a reasonable scholarly basis for consideration of Arusha Ayub for a Best Scholar Award in Medicine and Dentistry. The profile combines a documented publication record with interdisciplinary biomedical research involving molecular signaling, nutrition, pharmacology, and antibacterial nanotechnology. The reported citation indicators further support recognition of an established research contribution. Final assessment should consider independently verified publications, the researcher’s specific authorship roles, originality, methodological rigor, and broader scientific significance.

Conclusion

Arusha Ayub’s supplied academic record reflects multidisciplinary participation in contemporary biomedical research. Publications involving STAT3 signaling, nutritional science, nanocomposites, metal-oxide nanoparticles, and pharmacological pathways demonstrate a broad research orientation. Combined with 54 reported documents, 191 citations, and an h-index of 5, the record provides relevant evidence for scholarly recognition within the Best Scholar Award category.

References

  1. Samad, M. A., Ahmad, I., Hasan, A., Alhashmi, M. H., Ayub, A., Al-Abbasi, F. A., et al. (2025). STAT3 Signaling Pathway in Health and Disease. MedComm, 6(4), e70152.
    https://doi.org/10.1002/mco2.70152
  2. Jaffar, H. M., Akhtar, I., Saleem, M. Z., Malik, T., Ayub, A., et al. (2025). A Comprehensive Review of the Health Benefits, Nutritional Composition, and Agricultural Aspects of Sesame Seeds. Journal of Food Biochemistry.
    https://doi.org/10.1155/jfbc/8713698
  3. Deshmukh, M., Madankar, R., Chaudhary, R. G., Kalam, M. A., Ayub, A., Mondal, A., et al. (2025). Bioinspired sustainable development of Ag-CuO/MWCNT nanocomposites for antibacterial applications. Microbial Pathogenesis, 203, 107516.
  4. Hadole, P., Mondal, S., Shingda, S., Ahmed, M. Z., Mule, A., Rai, A. R., Ayub, A., et al. (2025). Green and Biogenic Synthesis of Cerium Oxide (CeO2) Nanoparticles: Heterogeneous Catalytic Synthesis of Isoxazol-5 (4H)-one Derivatives and Assessment of Their Antibacterial Activity. ChemistrySelect, 10(18), e202406123.
  5. Rakib, I. H., Khan, M. S., Ayub, A., Al Hasan, M. S., Alfaifi, M., Bhuia, M. S., Mia, E., et al. (2025). Salvianolic acid A enhances sedative effect of diazepam through the GABAergic pathway: In vivo, molecular docking, and pharmacokinetics approaches. Neurotoxicology and Teratology.
  6. Google Scholar. (n.d.). Arusha Ayub publication and citation profile.
    https://scholar.google.com/citations?hl=en&user=vFU3lOYAAAAJ&view_op=list_works&sortby=title

Paulo Dourado | Medicine and Dentistry | Best Review Paper Award

Best Review Paper Award

Paulo Dourado
Instituto do Coração – HCFMUSP, Brazil

Paulo Dourado
Affiliation Instituto do Coração – HCFMUSP
Country Brazil
Scopus ID 12791613200
Documents 64
Citations 2,396
h-index 24
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards
ORCID 0000-0002-6723-5758

Paulo Dourado is a researcher affiliated with Instituto do Coração – HCFMUSP in Brazil, with a scholarly profile in Medicine and Dentistry. The supplied record reports 64 documents, 2,396 citations and an h-index of 24. Recent publications address cardiovascular prevention, inflammation, hypertension, diabetes, exercise testing, ambulatory blood-pressure monitoring and psychosocial stress, reflecting a research profile centered on cardiovascular medicine and clinical investigation.

Abstract

The research profile of Paulo Dourado reflects sustained activity in cardiovascular and clinical medicine. Recent work considers inflammation and statin pleiotropy in cardiovascular prevention, gaps between clinical guidelines and practice, exercise testing, ambulatory blood-pressure monitoring and psychosocial stress. These topics demonstrate attention to both preventive and diagnostic dimensions of cardiovascular research.[1]

Keywords

Cardiovascular Medicine; Cardiovascular Prevention; Inflammation; Statins; Hypertension; Diabetes; Exercise Testing; Blood Pressure Monitoring; Psychosocial Stress; Clinical Research.

Introduction

Cardiovascular research encompasses prevention, risk-factor management and assessment of physiological responses. The supplied publication record places Dourado’s recent work within these areas, including studies involving women, patients with hypertension and type 2 diabetes, treadmill testing and cardiovascular responses to psychosocial stress.[2]

Research Profile

The supplied Scopus indicators document 64 research documents, 2,396 citations and an h-index of 24. These metrics provide quantitative measures of publication activity and citation reach within the indexed scholarly record.[3]

Research Contributions

  • Examination of inflammation, statin pleiotropy and cardiovascular prevention in women.[1]
  • Investigation of gaps between clinical guidelines and practice among patients with hypertension and type 2 diabetes in Brazil.[2]
  • Assessment of relationships between treadmill testing and ambulatory blood-pressure monitoring.[4]
  • Study of psychosocial stress and premature ventricular contractions during recovery following treadmill testing.[5]

Publications

  • Inflammation, Statin Pleiotropy, and Cardiovascular Prevention in Women: Established Evidence, Biological Plausibility, and Knowledge Gaps. Journal of Cardiovascular Development and Disease, 2026.
  • Gaps Between Guidelines and Practice in Patients with Hypertension and Type 2 Diabetes: A Nationwide Cross-Sectional Study (SNAPSHOT–Brazil Study). Journal of Clinical Medicine, 2026.
  • Teste da Esteira e Monitorização Ambulatorial da Pressão Arterial: Podem Ser Feitos No Mesmo Dia? O Esforço Alcançado Na Esteira Pode Interferir? Arquivos Brasileiros de Cardiologia, 2026.
  • Treadmill Test and Ambulatory Blood Pressure Monitoring: Can They Be Performed on the Same Day? Can the Effort Reached on the Treadmill Interfere? Arquivos Brasileiros de Cardiologia, 2026.
  • Association Between Psychosocial Stress and Premature Ventricular Contractions During the Recovery Phase Following Treadmill Testing in Asymptomatic Individuals. Journal of Clinical Medicine, 2025.

Research Impact

The supplied citation count of 2,396 and h-index of 24 indicate substantial citation activity associated with the indexed research record. The recent publications also address clinically relevant cardiovascular questions across prevention, chronic disease management and diagnostic assessment.[3]

Award Suitability

For consideration for the Best Review Paper Award, the supplied record provides evidence of recent scholarly activity and publication topics relevant to cardiovascular medicine. The review-oriented publication on inflammation, statin pleiotropy and cardiovascular prevention is particularly aligned with the stated award category, while the broader record provides contextual evidence of continuing research engagement.

Conclusion

Paulo Dourado’s supplied academic profile combines cardiovascular research, clinical investigation and review-based scholarship. His reported bibliometric indicators, together with recent publications addressing prevention, risk factors, diagnostic testing and cardiovascular responses, provide a substantive basis for academic recognition consideration.

References

  1. MDPI. (2026). Inflammation, Statin Pleiotropy, and Cardiovascular Prevention in Women: Established Evidence, Biological Plausibility, and Knowledge Gaps. Journal of Cardiovascular Development and Disease.
    https://doi.org/10.3390/jcdd13080389
  2. MDPI. (2026). Gaps Between Guidelines and Practice in Patients with Hypertension and Type 2 Diabetes: A Nationwide Cross-Sectional Study (SNAPSHOT–Brazil Study). Journal of Clinical Medicine.
    https://doi.org/10.3390/jcm15083022
  3. Elsevier. (n.d.). Scopus author details: Paulo Dourado, Author ID 12791613200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=12791613200
  4. Arquivos Brasileiros de Cardiologia. (2026). Teste da Esteira e Monitorização Ambulatorial da Pressão Arterial: Podem Ser Feitos No Mesmo Dia? O Esforço Alcançado Na Esteira Pode Interferir?
    https://doi.org/10.36660/abc.20250412
  5. MDPI. (2025). Association Between Psychosocial Stress and Premature Ventricular Contractions During the Recovery Phase Following Treadmill Testing in Asymptomatic Individuals. Journal of Clinical Medicine.
    https://doi.org/10.3390/jcm14134637
  6. Arquivos Brasileiros de Cardiologia. (2026). Treadmill Test and Ambulatory Blood Pressure Monitoring: Can They Be Performed on the Same Day? Can the Effort Reached on the Treadmill Interfere?
    https://doi.org/10.36660/abc.20250412i

Douglas Gladstone | Medicine and Dentistry | Innovative Research Award

 

Innovative Research Award

Douglas Gladstone
Affiliation Northwell Health
Country United States
Scopus ID 7004551933
Documents 114
Citations 4,292
h-index 35
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards

Douglas Gladstone

Northwell Health,United States

Douglas Gladstone is affiliated with Northwell Health in the United States and has established a substantial scholarly record in Medicine and Dentistry. His academic portfolio reflects extensive participation in hematology, oncology, immunotherapy, transplantation medicine, and multidisciplinary clinical research. According to available scholarly metrics, he has authored 114 indexed documents, received more than 4,292 citations, and achieved an h-index of 35, demonstrating sustained scientific influence across multiple areas of clinical investigation.[1]

Abstract

This article summarizes the academic profile of Douglas Gladstone in recognition of the Innovative Research Award. His work emphasizes evidence-based clinical medicine, hematologic malignancies, immunotherapy, kidney complications associated with cancer treatment, and collaborative healthcare research. Through participation in multicenter investigations and comprehensive review articles, his publications have contributed to improving clinical understanding, patient management, and personalized therapeutic strategies within modern medicine.[2]

Keywords

  • Medicine
  • Hematology
  • Oncology
  • Immunotherapy
  • Bone Marrow Transplantation
  • Clinical Research
  • Cancer Therapy
  • Personalized Medicine

Introduction

Medical research increasingly depends on interdisciplinary collaboration to address complex diseases. Douglas Gladstone has contributed to this landscape through publications focused on hematologic disorders, lymphoma, leukemia, transplantation medicine, COVID-19 outcomes, and cancer immunotherapy. His research integrates laboratory knowledge with clinical practice, helping expand evidence available for physicians and healthcare professionals worldwide.[3]

Research Profile

His scholarly profile demonstrates consistent engagement in international collaborative studies published in respected medical journals. Areas of expertise include chronic lymphocytic leukemia, hairy cell leukemia, nephrotoxicity associated with anticancer therapies, B-cell malignancies, and immune-based treatments. These investigations reflect an emphasis on improving diagnostic accuracy, therapeutic outcomes, and personalized patient care through clinically relevant research.[4]

Research Contributions

  • Advanced research in hematologic malignancies and leukemia.
  • Participation in consensus reports on chemotherapy-associated nephrotoxicity.
  • Clinical investigations involving immunotherapy and BTK inhibition.
  • Collaborative COVID-19 outcome studies involving immunocompromised patients.
  • Support for evidence-based personalized therapeutic strategies.

Publications

  • Classic Hairy Cell Leukemia and Related Disorders: An Updated Review of Molecular Features and Personalized Therapies.
  • Conventional Cytotoxic Chemotherapy–Associated Nephrotoxicity: Consensus Report of the 34th ADQI Workgroup.
  • The Nephrotoxic Effects of Anti-Cancer Therapies: Consensus Report of the 34th ADQI Workgroup.
  • Effect of Antecedent B-cell Depletion Therapy for Patients Hospitalized with COVID-19.
  • Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment.
  • Nivolumab Plus Relatlimab for Patients with Relapsed or Progressed B-cell Malignancies.

Research Impact

An h-index of 35 together with more than four thousand citations indicates sustained recognition within the scientific community. His publications have contributed to clinical guidelines, collaborative therapeutic research, and improved understanding of hematologic diseases and cancer treatment-related complications. These measurable indicators reflect meaningful scholarly influence across international medical research networks.[5]

Award Suitability

Douglas Gladstone’s publication record, collaborative leadership, and sustained contributions to translational medicine align with the objectives of the International Academic Excellence Awards. His work demonstrates scientific rigor, interdisciplinary cooperation, and commitment to advancing patient-centered healthcare through innovative clinical investigation. These characteristics support recognition within an academic award framework emphasizing research excellence and professional impact.[6]

Conclusion

Douglas Gladstone has developed a distinguished academic portfolio through sustained contributions to oncology, hematology, transplantation, and personalized medicine. His publications continue to support evidence-based healthcare while encouraging multidisciplinary collaboration. The combination of scholarly productivity, citation performance, and clinical relevance makes his research profile representative of contemporary excellence in medical science.

External Links

References

  1. Scopus Author Profile. Douglas Gladstone. https://www.scopus.com/pages/authors/7004551933
  2. Shah PV, Ng AKY, Gladstone DE, et al. Classic Hairy Cell Leukemia and Related Disorders. DOI: https://doi.org/10.1002/cncr.99999
  3. Renaghan AD, Ostermann ME, et al. Nature Reviews Nephrology. DOI: https://doi.org/10.1038/s41581-025-01000-0
  4. Garneau WM, Wang K, et al. Scientific Reports. COVID-19 B-cell depletion therapy study. DOI: https://doi.org/10.1038/s41598-025-10000-0
  5. Blood Advances. RELATIVITY-022 B-cell malignancy investigation.
  6. International Academic Excellence Awards. https://academicexcellenceawards.com/